1. Home
  2. MDAIW vs EICC Comparison

MDAIW vs EICC Comparison

Compare MDAIW & EICC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDAIW
  • EICC
  • Stock Information
  • Founded
  • MDAIW N/A
  • EICC N/A
  • Country
  • MDAIW United States
  • EICC United States
  • Employees
  • MDAIW 78
  • EICC N/A
  • Industry
  • MDAIW Medical/Dental Instruments
  • EICC
  • Sector
  • MDAIW Health Care
  • EICC
  • Exchange
  • MDAIW Nasdaq
  • EICC Nasdaq
  • Market Cap
  • MDAIW N/A
  • EICC N/A
  • IPO Year
  • MDAIW N/A
  • EICC N/A
  • Fundamental
  • Price
  • MDAIW $0.65
  • EICC $25.27
  • Analyst Decision
  • MDAIW
  • EICC
  • Analyst Count
  • MDAIW 0
  • EICC 0
  • Target Price
  • MDAIW N/A
  • EICC N/A
  • AVG Volume (30 Days)
  • MDAIW 35.6K
  • EICC 18.7K
  • Earning Date
  • MDAIW 02-27-2025
  • EICC 01-01-0001
  • Dividend Yield
  • MDAIW N/A
  • EICC 7.96%
  • EPS Growth
  • MDAIW N/A
  • EICC N/A
  • EPS
  • MDAIW N/A
  • EICC 0.55
  • Revenue
  • MDAIW $27,264,000.00
  • EICC $51,224,692.00
  • Revenue This Year
  • MDAIW N/A
  • EICC $39.61
  • Revenue Next Year
  • MDAIW N/A
  • EICC $27.28
  • P/E Ratio
  • MDAIW N/A
  • EICC $23.44
  • Revenue Growth
  • MDAIW 44.52
  • EICC 68.61
  • 52 Week Low
  • MDAIW $0.08
  • EICC $23.75
  • 52 Week High
  • MDAIW $0.90
  • EICC $25.25
  • Technical
  • Relative Strength Index (RSI)
  • MDAIW 43.03
  • EICC 66.15
  • Support Level
  • MDAIW $0.64
  • EICC $25.04
  • Resistance Level
  • MDAIW $0.80
  • EICC $25.26
  • Average True Range (ATR)
  • MDAIW 0.12
  • EICC 0.07
  • MACD
  • MDAIW -0.03
  • EICC 0.01
  • Stochastic Oscillator
  • MDAIW 9.18
  • EICC 99.65

About MDAIW Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

About EICC Eagle Point Income Company Inc. 8.00% Series C Term Preferred Stock due 2029

Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.

Share on Social Networks: